- Source type
- Article
- Access type
- Publisher
- Publisher
- Indiana Public Media
- Date
- 2026-07-01
- Added
- 2026-07-05
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
60
General published source
- Publisher type
- General media
- Bias profile
- Elevated
This source is strongest for consumer context and regulatory status and weaker for safety and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 54/100
- Weak Support
- Clinical outcomes
- 54/100
- Weak Support
- Mechanism
- 54/100
- Weak Support
- Safety
- 54/100
- Weak Support
- Consumer context
- 67/100
- Context Source
- Trial discovery
- 54/100
- Weak Support
Best used for
- Context
- Public narrative
Weak for
- Clinical claims
- Safety conclusions
- Regulatory status
Used in Viral Vitalism
Teen Became First Pediatric Patient Saved by Deceased-Donor Stem Cells
Roles: Background
Related studies
No structured study record is currently attached to this source.
Related sources
ClinicalTrials.gov: ReMIND trial
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
FDA: Tregzi approval press announcement
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
Brighter Day campaign page
Campaign context; confirm specific hospital capability, timeline, and patient pathway before publication.
- Trust score
- 60
- Publisher
- Brighter Lives Townsville Hospital Foundation
- Access
- Publisher
- Usage
- 0 connections
Children's National: first-of-its-kind cell therapy trial in aggressive brain tumors
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Children's National
- Access
- Publisher
- Usage
- 1 connection
Courier Mail: Townsville cancer treatment access campaign
Local reporting with likely paywall constraints; verify with primary hospital/foundation source before publishing.
- Trust score
- 60
- Publisher
- Courier Mail
- Access
- Publisher
- Usage
- 0 connections
Orca Bio: Phase 3 Precision-T data background
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Orca Bio
- Access
- Publisher
- Usage
- 1 connection